Cure® Unveils US Biotech Industry Benchmark Report 2024: Dark Days of 2023 are Over

79% respondents predict growth in 2024 and beyond Nearly half anticipate increasing R&D spend Neurology and metabolic diseases ranked top therapeutic areas of interest Interest in drug discovery overtakes digital health Most view women’s health as a priority, but agree funding is…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.